|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease显示文摘 | Tang B Xiong H Sun P Zhang Y Wang D Hu Z Zhu Z Ma H Pan Q Xia JH Xia K Zhang Z | 2006 | 中国生物学文摘2006，20，8： | 30 |
| 2 | 非酒精性脂肪性肝病中脂毒性肝细胞来源的外泌体miR-192-5p通过Rictor/Akt/FoxO1信号通路激活巨噬细胞显示文摘【据Hepatology 2020年5月报道】题:非酒精性脂肪性肝病中脂毒性肝细胞来源的外泌体miR-192-5p通过Rictor/Akt/FoxO1信号通路激活巨噬细胞(作者Liu XL等)肝脏巨噬细胞可被多种因素如肠道菌群代谢物以及受损的肝细胞释放物等激活。在非酒精性脂肪性肝病(NAFLD)的发生发展中,巨噬细胞向促炎表型(M1)的极化是一个重要的病理生理过程。外泌体可传递多种生物学成分如microRNA、蛋白质以及脂质等,因此被作为细胞间通讯的重要媒介。在NAFLD的发生发展过程中,外泌体在肝细胞与巨噬细胞对话中的作用尚未明确。 | 刘晓琳 范建高 LIU XL PAN Q CAO HX | 2020 | 临床肝胆病杂志2020，36，10： | 28 |
| 3 | Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3显示文摘AIM: To investigate the inhibitory role and the underlying mechanisms of sorafenib on signal transducer and activator of transcription 3 (STAT3) activity in hepatocellular carcinoma (HCC).METHODS: Human and rat HCC cell lines were treated with sorafenib. Proliferation and STAT3 dephosphorylation were assessed. Potential molecular mechanisms of STAT3 pathway inhibition by sorafenib were evaluated. In vivo antitumor action and STAT3 inhibition were investigated in an immunocompetent orthotopic rat HCC model.RESULTS: Sorafenib decreased STAT3 phosphorylationat the tyrosine and serine residues (Y705 and S727), but did not affect Janus kinase 2 (JAK2) and phosphatase shatterproof 2 (SHP2), which is associated with growth inhibition in HCC cells. Dephosphorylation of S727 was associated with attenuated extracellular signal-regulated kinase (ERK) phosphorylation, similar to the effects of a mitogen-activated protein kinase (MEK) inhibitor U0126, suggesting that sorafenib induced S727 dephosphorylation by inhibiting MEK/ERK signaling. Meanwhile, sorafenib could also inhibit Akt phosphorylation, and both the phosphatidylinositol-3-kinase (PI3K) inhibitor LY294002 and Akt knockdown resulted in Y705 dephosphorylation, indicating that Y705 dephosphorylation by sorafenib was mediated by inhibiting the PI3K/Akt pathway. Finally, in the rat HCC model, sorafenib signifi cantly inhibited STAT3 activity, reducing tumor growth and metastasis.CONCLUSION: Sorafenib inhibits growth and metastasis of HCC in part by blocking the MEK/ERK/STAT3 and PI3K/Akt/STAT3 signaling pathways, but independent of JAK2 and SHP2 activation. | Fang-Ming Gu, Quan-Lin Li, Qiang Gao, Jia-Hao Jiang, Xiao-Yong Huang, Jin-Feng Pan, Jia Fan, Jian ZhouFang-Ming Gu, Quan-Lin Li, Qiang Gao, Jia-Hao Jiang, Xiao-Yong Huang, Jin-Feng Pan, Jia Fan, Jian Zhou, Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Shanghai 200032, China Author contributions: Gu FM, Li QL and Gao Q contributed equally to this work Gu FM and Li QL performed the experi- ments and interpretation of the data and statistical analysis Zhou J and Gao Q contributed to the conception and design of the study Gu FM, Gao Q, Li QL and Zhou J wrote the manuscript Jiang JH, Huang XY, Pan JF and Fan J made substantial contri- bution to the design and conception of the study and interpreta- tion of data all authors read and approved the f inal manuscript. | 2011 | World Journal of Gastroenterology2011，17，34： | 18 |
| 4 | 慢性肾脏病中的炎症和动脉硬化:慢性肾功能不全队列研究中的发现显示文摘慢性肾脏病(chronic kidney disease,CKD)和动脉硬化程度与心血管病发病率和死亡率增加相关。目前认为炎症在动脉硬化发展中发挥作用,而CKD被认为是一种促炎症反应的状态。CKD患者的动脉僵硬度增加,横断面数据提示CKD中增多的炎症标志物与较高动脉僵硬度值相关。 | Peyster E Chen J Feldman HI Go AS Gupta J Mitra N Pan Q Porter A Rahman M Raj D Reilly M Wing MR Yang W Townsend RR 陈云 叶鹏 | 2017 | 中华高血压杂志2017，25，11： | 12 |
| 5 | Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B显示文摘AIM:To compare the efficacy and safety of tenofovir disoproxil fumarate(TDF)in Asian and non-Asian chronic hepatitis B(CHB)patients.METHODS:The efficacy and safety of the initial 48wk of treatment with TDF was compared in a posthoc analysis of combined data from 217 Asians and299 non-Asians included in Studies 102 and 103and a post-approval,open-label trial(Study 123).Patient groups were compared according to baseline hepatitis B e antigen(HBe Ag)status and viral load.The main outcome measures included the proportion of patients who achieved a hepatitis B virus(HBV)DNA level<400 copies/m L at Week 48 of treatment.Secondary measures included:HBV DNA and alanine aminotransaminase(ALT)levels over time;proportion of patients with normal ALT levels;proportion of patients with HBe Ag loss/seroconversion and proportion of patients with hepatitis B surface antigen loss/seroconversion;changes in liver histology.Safety and tolerability were evaluated by the occurrence of adverse events(AEs),serious AEs,laboratory abnormalities,discontinuation of the study drug due to AEs,or death.The primary efficacy and safety analysis set included all patients who were randomly assigned to treatment and received at least one dose of study drug.RESULTS:At week 48,similar proportions of Asians and non-Asians reached HBV DNA<400 copies/m L(96%of Asian and 97%of non-Asian patients with HBe Ag-negative CHB and 83%of Asian and 79%of non-Asian patients with HBe Ag-positive CHB had HBV DNA)and normal ALT(78%of Asian and 81%of nonAsian patients with HBe Ag-negative CHB and 71%of Asian and 74%of non-Asian patients with HBe Agpositive CHB had normal ALT).On-treatment HBV DNA decline rates were similar between Asians and nonAsians regardless of baseline HBe Ag status and viralload.HBV DNA decline during the first four weeks was2.9 log10 copies/m L in HBe Ag-negative Asians and nonAsians,and in HBe Ag-positive non-Asians,and 3.1log10 copies/m L in HBe Ag-positive Asians.HBe Ag loss and seroconversion was achieved in 14%of Asians vs 26%and 24%,respectively,in non-Asians.Liver histology improved in 77.2%of Asians and 71.5%of non-Asians.No resistance to TDF developed.No renal safety signals were observed.CONCLUSION:TDF demonstrated similar viral suppression,normalization of ALT,improvements in liver fibrosis,and no detectable resistance in Asian and non-Asian patients regardless of baseline HBe Ag status. | Calvin Q Pan Sing Chan Huy Trinh Alan Yao Ho Bae Lillian Lou | 2015 | World Journal of Gastroenterology2015，21，18： | 4 |
| 6 | 饲料中添加蛋白酶对肉鸡性能、养分利用率、肠道形态和胴体品质的影响显示文摘试验在饲喂玉米、高粱为主的肉鸡日粮中补充大豆,并添加蛋白酶,研究蛋白酶对肉鸡性能、养分消化率、肠道形态和胴体品质的影响。试验选取1日龄AA肉仔鸡(43.8±1.31 g)256只,均为公鸡,随机分配到2×2试验设计方阵中,方阵包括正常组(玉米组和高粱组)和蛋白酶组(空白组和添加蛋白酶150 mg·kg^(-1)的试验组)。试验1~21 d为第一阶段,22~42 d为第二阶段。试验结果表明,第二阶段中,日粮中添加蛋白酶极显著提高肉鸡的平均日增重(ADG,P<0.01),在整个试验过程中显著提高(P<0.05)。在各个时期,正常组对肉鸡生产性能均无显著影响(P>0.05)。19~21 d时,添加蛋白酶可显著提高肉鸡的表观代谢能(AME),干物质(DM)、总能量(GE)和养分消化率(P<0.05)。此外,日粮以高粱为主时,AME、GE消化率有降低趋势(P=0.05),氮沉积率也有降低趋势(P=0.08)。40~42 d时,日粮中添加蛋白酶可显著提高AME,DM、GE和氮沉积率(P<0.05)。21 d时,日粮中添加蛋白酶极显著增加肠绒毛高度、肠绒毛与隐窝深度比值,极显著降低十二指肠、空肠、回肠的隐窝深度(P<0.01)。42 d时,日粮中添加蛋白酶显著增加空肠肠绒毛高度、绒毛高度与隐窝深度比值,显著降低隐窝深度(P<0.05)。日粮中添加蛋白酶显著增加胸肌重、24 h p H,显著降低胸肌的滴水损失(P<0.05)。试验结果表明,饲养阶段日粮中添加复合蛋白酶可提高肉鸡ADG;在第一阶段可改善AME、DM、GE和氮沉积率和肠道形态。补充蛋白酶可提高出栏重、胸肌重和24 h pH,降低胸肌的滴水损失。低单宁高粱日粮与玉米日粮相比,对肉鸡性能的影响相近。 | Xu X Wang H L Pan L Ma X K Tian Q Y Xu Y T Long S F Zhang Z H Piao X S | 2017 | 饲料博览2017，0，1： | 2 |
| 7 | PCBs, PCNs and PBDEs in sedin2ents and mussels from Qingdso coastal sea in the frame of current circulations and influence of sewage sludge 显示文摘 | PAN J YANG Y L XU Q etal | 2007 | Chemosphere2007，66，： | 1 |
| 8 | A novel functionally graded material in the Ti-Si-C system显示文摘 | LUO Y G PAN W LI S Q WANG R G LI J Q | 2003 | Mater Sci Eng A2003，345，： | 1 |
| 9 | A Novel Differential Evolution Algorithm for Bi-criteria No-wait Flow Shop Scheduling Problems显示文摘 | PAN Q K WANG L QIAN B | 2009 | Computers and Operations Research2009，36，8： | 1 |
| 10 | Divergent evolution of plant NBS-LRR resistance gene homologues in dicot and cereal genomes 显示文摘 | Pan Q L Wendel J Fluhr R | 2000 | Journal of Molecular Evolution2000，50，： | 1 |
| 11 | Storage and sequestration potential of topsoil organic carbon in China paddy soil显示文摘 | PAN Gen-Xing Li L Q Wu L S | 2003 | Global Change Biology2003，10，： | 1 |
| 12 | Magnetic domain observations of freestanding single crystal patterned Ni2MnGa films 显示文摘 | PAN Q DONG J W PALMSTROM C J | 2002 | Journal of Applied Physics2002，91，10： | 1 |
| 13 | A discrete artificial bee colony algorithm for the lot- streaming flow shop scheduling problem显示文摘 | PAN Q FATIH TASGETIREN M SUGANTHAN P N etal | 2011 | Information Sciences2011，181，12： | 1 |
| 14 | Protein kinase C epsilon:an oncogeneand emerging tumor biomarker显示文摘 | Gorin M A Pan Q | 2009 | Mol Cancer2009，8，： | 1 |
| 15 | A revaluation of the systematic position of the cercidiphylaceae and daphniphyllaceae based on rbcL gene sequence analysis,with reference to the relationship in the 'lower' Hamamelidae显示文摘 | FENG Y X(俸宇星) WANG X Q(汪小全) PAN K Y(潘开玉) | 1998 | Acta Phytotaxonomica Sinica(植物分类学报)1998，36，5： | 1 |
| 16 | Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction usingall -trans retinoic acid显示文摘 | PAN X Q ZHENG X SHI G | 2002 | Blood2002，100，2： | 1 |
| 17 | Palmprint recognition using Gabor-based local invariant features显示文摘 | Pan X Ruan Q | 2009 | Neurocomputing2009，72，79： | 1 |
| 18 | A Dif- ferential Evolution Algorithm with Self-Adapting Strategy and Control Parameters 显示文摘 | PAN Q K SUGANTHAN P N WANG L | 2011 | Computers and Operations Research2011，38，1： | 1 |
| 19 | 显示文摘 | He J B Lin X Q Pan J | 2005 | Electroanal2005，17，18： | 1 |
| 20 | Comparison of spectral and image morphological analysis for egg early hatching propertydetection based on hyperspectral imaging 显示文摘 | Zhang W Pan L Q Tu K | 2014 | Plos ONE2014，9，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员